4.7 Article

sROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis

F. Nikulenkov et al.

CELL DEATH AND DIFFERENTIATION (2012)

Article Biochemistry & Molecular Biology

Abrogation of Wip1 expression by RITA-activated p53 potentiates apoptosis induction via activation of ATM and inhibition of HdmX

C. Spinnler et al.

CELL DEATH AND DIFFERENTIATION (2011)

Review Pharmacology & Pharmacy

Recent Advances in the Therapeutic Perspectives of Nutlin-3

Paola Secchiero et al.

CURRENT PHARMACEUTICAL DESIGN (2011)

Article Biochemistry & Molecular Biology

Inhibition of Glycolytic Enzymes Mediated by Pharmacologically Activated p53 TARGETING WARBURG EFFECT TO FIGHT CANCER

Joanna Zawacka-Pankau et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Editorial Material Genetics & Heredity

New insights into oncogenic stress

Kevin M. Haigis et al.

NATURE GENETICS (2011)

Article Genetics & Heredity

The stress kinase MKK7 couples oncogenic stress to p53 stability and tumor suppression

Daniel Schramek et al.

NATURE GENETICS (2011)

Review Oncology

The biological and therapeutic relevance of mRNA translation in cancer

Sarah P. Blagden et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2011)

Article Biochemistry & Molecular Biology

Resveratrol prevents RANKL-induced osteoclast differentiation of murine osteoclast progenitor RAW 264.7 cells through inhibition of ROS production

Xu He et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)

Article Biochemistry & Molecular Biology

Noble metal targeting of thioredoxin reductase - covalent complexes with thioredoxin and thioredoxin-related protein of 14 kDa triggered by cisplatin

Stefanie Prast-Nielsen et al.

FREE RADICAL BIOLOGY AND MEDICINE (2010)

Article Biochemistry & Molecular Biology

Wild-type p53-induced Phosphatase 1 Dephosphorylates Histone Variant γ-H2AX and Suppresses DNA Double Strand Break Repair

Sung-Hwan Moon et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Biotechnology & Applied Microbiology

Role of oxidatively induced DNA lesions in human pathogenesis

Olga A. Sedelnikova et al.

MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2010)

Article Multidisciplinary Sciences

Selective activation of p53-mediated tumour suppression in high-grade tumours

Melissa R. Junttila et al.

NATURE (2010)

Article Multidisciplinary Sciences

Stage-specific sensitivity to p53 restoration during lung cancer progression

David M. Feldser et al.

NATURE (2010)

Article Multidisciplinary Sciences

A minority of foci or pan-nuclear apoptotic staining of γH2AX in the S phase after UV damage contain DNA double-strand breaks

Sebastien de Feraudy et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Review Oncology

Therapeutic targeting of p53 by small molecules

Galina Selivanova

SEMINARS IN CANCER BIOLOGY (2010)

Review Biochemistry & Molecular Biology

WIP1 phosphatase at the crossroads of cancer and aging

Xavier Le Guezennec et al.

TRENDS IN BIOCHEMICAL SCIENCES (2010)

Review Biochemistry & Molecular Biology

Selenoproteins that function in cancer prevention and promotion

Dolph L. Hatfield et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2009)

Review Biochemistry & Molecular Biology

Blinded by the Light: The Growing Complexity of p53

Karen H. Vousden et al.

Review Biochemistry & Molecular Biology

Mcl-1 is a potential therapeutic target in multiple types of cancer

C. Akgul

CELLULAR AND MOLECULAR LIFE SCIENCES (2009)

Review Biotechnology & Applied Microbiology

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

Dunyaporn Trachootham et al.

NATURE REVIEWS DRUG DISCOVERY (2009)

Review Oncology

Awakening guardian angels: drugging the p53 pathway

Christopher J. Brown et al.

NATURE REVIEWS CANCER (2009)

Review Oncology

The PIK3CA Gene as a Mutated Target for Cancer Therapy

John P. Gustin et al.

CURRENT CANCER DRUG TARGETS (2008)

Review Cell Biology

Transcriptional control of human p53-regulated genes

Todd Riley et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)

Article Multidisciplinary Sciences

Cell Death by SecTRAPs: Thioredoxin Reductase as a Prooxidant Killer of Cells

Karin Anestal et al.

PLOS ONE (2008)

Article Biochemistry & Molecular Biology

Apoptosis by cisplatin requires p53 mediated p38α MAPK activation through ROS generation

Paloma Bragado et al.

APOPTOSIS (2007)

Article Biochemistry & Molecular Biology

Inhibition of thioredoxin reductase induces apoptosis in neuronal cell lines:: Role of glutathione and the MKK4/JNK pathway

Jan Seyfried et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)

Article Biochemistry & Molecular Biology

Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells

Christine Marzano et al.

FREE RADICAL BIOLOGY AND MEDICINE (2007)

Article Cell Biology

MDMX: from bench to bedside

Jean-Christophe W. Marine et al.

JOURNAL OF CELL SCIENCE (2007)

Review Oncology

On the potential of thioredoxin reductase inhibitors for cancer therapy

Sabine Urig et al.

SEMINARS IN CANCER BIOLOGY (2006)

Review Oncology

The thioredoxin system in cancer

Elias S. J. Arner et al.

SEMINARS IN CANCER BIOLOGY (2006)

Article Biochemical Research Methods

Clustering microarray gene expression data using weighted Chinese restaurant process

Zhaohui S. Qin

BIOINFORMATICS (2006)